X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with LINC PEN &PL - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs LINC PEN & PLASTICS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES LINC PEN & PLASTICS AMAR REMEDIES/
LINC PEN & PLASTICS
 
P/E (TTM) x -0.5 15.8 - View Chart
P/BV x 0.1 2.8 2.1% View Chart
Dividend Yield % 0.0 1.6 -  

Financials

 AMAR REMEDIES   LINC PEN & PLASTICS
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
LINC PEN & PLASTICS
Mar-16
AMAR REMEDIES/
LINC PEN & PLASTICS
5-Yr Chart
Click to enlarge
High Rs164243 67.6%   
Low Rs86136 63.2%   
Sales per share (Unadj.) Rs261.6232.7 112.4%  
Earnings per share (Unadj.) Rs17.412.4 140.4%  
Cash flow per share (Unadj.) Rs22.316.4 135.7%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Dividend yield (eoy) %01.6 0.0%  
Book value per share (Unadj.) Rs100.768.4 147.3%  
Shares outstanding (eoy) m26.1614.79 176.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.50.8 58.7%   
Avg P/E ratio x7.215.3 47.0%  
P/CF ratio (eoy) x5.611.5 48.6%  
Price / Book Value ratio x1.22.8 44.8%  
Dividend payout %024.2 0.0%   
Avg Mkt Cap Rs m3,2702,800 116.8%   
No. of employees `000NA0.7 0.0%   
Total wages/salary Rs m163186 87.8%   
Avg. sales/employee Rs ThNM5,167.3-  
Avg. wages/employee Rs ThNM278.8-  
Avg. net profit/employee Rs ThNM275.1-  
INCOME DATA
Net Sales Rs m6,8443,441 198.9%  
Other income Rs m217 284.6%   
Total revenues Rs m6,8653,449 199.1%   
Gross profit Rs m1,131314 360.3%  
Depreciation Rs m12860 214.6%   
Interest Rs m39815 2,601.3%   
Profit before tax Rs m626246 254.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m12163 191.5%   
Profit after tax Rs m455183 248.4%  
Gross profit margin %16.59.1 181.2%  
Effective tax rate %19.325.6 75.4%   
Net profit margin %6.65.3 124.9%  
BALANCE SHEET DATA
Current assets Rs m4,9041,334 367.7%   
Current liabilities Rs m3,581802 446.7%   
Net working cap to sales %19.315.5 125.0%  
Current ratio x1.41.7 82.3%  
Inventory Days Days12482 151.6%  
Debtors Days Days10051 197.9%  
Net fixed assets Rs m1,689437 386.2%   
Share capital Rs m262148 177.2%   
"Free" reserves Rs m2,358863 273.1%   
Net worth Rs m2,6351,011 260.6%   
Long term debt Rs m5070-   
Total assets Rs m6,8621,855 370.0%  
Interest coverage x2.617.1 15.0%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.9 53.8%   
Return on assets %12.410.7 116.2%  
Return on equity %17.318.1 95.3%  
Return on capital %31.025.9 119.8%  
Exports to sales %4.027.9 14.3%   
Imports to sales %016.0 0.0%   
Exports (fob) Rs m273959 28.5%   
Imports (cif) Rs mNA552 0.0%   
Fx inflow Rs m273960 28.4%   
Fx outflow Rs m2577 0.3%   
Net fx Rs m271383 70.7%   
CASH FLOW
From Operations Rs m-31397 -322.6%  
From Investments Rs m-489-185 264.5%  
From Financial Activity Rs m76974 1,037.5%  
Net Cashflow Rs m-33-14 236.5%  

Share Holding

Indian Promoters % 25.5 60.4 42.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 39.6 164.9%  
Shareholders   13,061 6,688 195.3%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   K.S.OILS LTD  BATA INDIA  JYOTHY LABS  ARCHIES LTD  GILLETTE INDIA  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Slips below 38,000-Mark; Yes Bank Jumps 9%(12:30 pm)

Share markets in India are presently trading deep in the red as investors were disappointed after the government refused any respite to foreign investors.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

7 Stocks to Profit From an Irreversible Trend(The 5 Minute Wrapup)

Jul 18, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - P&G HYGIENE COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS